GLP-1 drugs are widely used in this population, yet robust clinical guidance is still evolving
Translating mechanism knowledge to patient outcomes Bridging molecular biology and clinical practice
Conclusion GLP-1RA reduced the risk of MI, stroke, cardiovascular mortality and MACE in a broad range of patients with and without T2DM and/or prior ASCVD, supporting its role in ASCVD prevention, especially in the cohort with high BMI
Bariatric surgery, meanwhile, carries its own commitments, including adjusting diet and vitamin intake, however its effects can last a lifetime
Glutathione is an important antioxidant and an essential cofactor for antioxidant enzymes, providing protection for functional proteins via the redox buffer for sulfhydryl [8, 9]